Chemical Structure : CDKI-73
CAS No.: 1421693-22-2
Catalog No.: PC-43037Not For Human Use, Lab Use Only.
Asnuciclib (CDKI-73) is a potent CDK9 inhibitor with Ki of 4 nM, shows cytotoxicity against a broad CLL samples with mean LD50 of 80 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $248 | In stock | |
10 mg | $428 | In stock | |
25 mg | $728 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Asnuciclib (CDKI-73) is a potent CDK9 inhibitor with Ki of 4 nM, shows cytotoxicity against a broad CLL samples with mean LD50 of 80 nM.
CDKI-73 induces caspase-dependent apoptosis that was preceded by dephosphorylation of CDK9 and serine 2 of RNA polymerase II.
CDKI-73 is more potent than the pan-CDK inhibitor Flavopiridol and shows >200-fold selectivity against primary leukemia cells when compared with normal CD34+ cells.
CDKI-73 shows cytotoxic synergy with the nucleoside analog fludarabine in in poor prognostic sub-groups of leukemia patients, which is associated with CDKI-73-mediated transcriptional inhibition of MCL1 and XIAP.
M.Wt | 394.447 | |
Formula | C15H15FN6O2S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Benzenesulfonamide, 3-[[5-fluoro-4-[4-methyl-2-(methylamino)-5-thiazolyl]-2-pyrimidinyl]amino]- |
1. Walsby E, et al. Oncotarget. 2014 Jan 30;5(2):375-85.
2. Lam F, et al. Oncotarget. 2014 Sep 15;5(17):7691-704.
3. Cao S, et al. Biochem Biophys Res Commun. 2017 Jan 22;482(4):536-541.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright